Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Alzheimer's Disease

Free Subscription Articles published in Science Retrieve available abstracts of 35 articles: HTML format

Single Articles

September 2023
1. BALUSU S, Horre K, Thrupp N, Craessaerts K, et al
   MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer's disease.
   Science. 2023;381:1176-1182.
   PubMed     Abstract available
   
   
   
2. SIRKIS DW, Yokoyama JS
   Role for cell death pathway in Alzheimer's disease.
   Science. 2023;381:1156-1157.
   PubMed     Abstract available
   
   
   
3. AGUZZI A, Kampmann M
   Neurodegeneration enters the era of functional genomics.
   Science. 2023;381:eadk5693.
   PubMed     Abstract available
   
   
   August 2023
4. COUZIN-FRANKEL J
   Side effects loom over Alzheimer's drugs.
   Science. 2023;381:466-467.
   PubMed     Abstract available
   
   
   July 2023
5. ZHANG ZY, Harischandra DS, Wang R, Ghaisas S, et al
   TRIM11 protects against tauopathies and is down-regulated in Alzheimer's disease.
   Science. 2023;381:eadd6696.
   PubMed     Abstract available
   
   
   May 2023
6. TRAVIS J
   Latest Alzheimer's antibody is 'not a miracle drug'.
   Science. 2023;380:571.
   PubMed     Abstract available
   
   
   April 2023
7. PILLER C
   Report on trial death stokes Alzheimer's drug fears.
   Science. 2023;380:122-123.
   PubMed     Abstract available
   
   
   
8. COUZIN-FRANKEL J
   Promising Alzheimer's therapies shrink brains.
   Science. 2023;380:19.
   PubMed     Abstract available
   
   
   January 2023
9. COUZIN-FRANKEL J
   Alzheimer's drug approval gets a mixed reception.
   Science. 2023;379:126-127.
   PubMed     Abstract available
   
   
   December 2022
10. COUZIN-FRANKEL J, Piller C
    Alzheimer's drug stirs excitement-and concerns.
    Science. 2022;378:1030-1031.
    PubMed     Abstract available
    
    
    November 2022
11. PILLER C
    Whistleblower finds possible misconduct in his own papers.
    Science. 2022;378:694-695.
    PubMed     Abstract available
    
    
    
12. ENDO F, Kasai A, Soto JS, Yu X, et al
    Molecular basis of astrocyte diversity and morphology across the CNS in health and disease.
    Science. 2022;378:eadc9020.
    PubMed     Abstract available
    
    
    September 2022
13. HOFFMANN HM
    Boosting cognition with a hormone.
    Science. 2022;377:1042-1043.
    PubMed     Abstract available
    
    
    August 2022
14. ASHE KH
    Alzheimer's target still viable but untested.
    Science. 2022;377:935.
    PubMed    
    
    
    
15. SELKOE D, Cummings J
    News story miscasts Alzheimer's science.
    Science. 2022;377:934-935.
    PubMed    
    
    
    
16. COOPER YA, Teyssier N, Drager NM, Guo Q, et al
    Functional regulatory variants implicate distinct transcriptional networks in dementia.
    Science. 2022;377:eabi8654.
    PubMed     Abstract available
    
    
    July 2022
17. PILLER C
    Research backing experimental Alzheimer's drug was first target of suspicion.
    Science. 2022;377:363.
    PubMed    
    
    
    
18. PILLER C
    Research backing experimental Alzheimer's drug was first target of suspicion.
    Science. 2022;377:363.
    PubMed    
    
    
    
19. PILLER C
    Blots on a field?
    Science. 2022;377:358-363.
    PubMed     Abstract available
    
    
    
20. ZHOU X, Sumrow L, Tashiro K, Sutherland L, et al
    Mutations linked to neurological disease enhance self-association of low-complexity protein sequences.
    Science. 2022;377:eabn5582.
    PubMed     Abstract available
    
    
    January 2022
21. YANG Y, Arseni D, Zhang W, Huang M, et al
    Cryo-EM structures of amyloid-beta 42 filaments from human brains.
    Science. 2022;375:167-172.
    PubMed     Abstract available
    
    
    December 2021
22. LESLIE M
    Blood condition may guard against Alzheimer's.
    Science. 2021;374:1425.
    PubMed     Abstract available
    
    
    October 2021
23. SELKOE DJ
    Alzheimer's drugs: Does reducing amyloid work?-Response.
    Science. 2021;374:545-546.
    PubMed    
    
    
    
24. THAMBISETTY M, Howard R, Glymour MM, Schneider LS, et al
    Alzheimer's drugs: Does reducing amyloid work?
    Science. 2021;374:544-545.
    PubMed    
    
    
    
25. SPIRES-JONES T
    Toward a holistic model of Alzheimer'sHow Not to Study a Disease: The Story of Alzheimer's Karl Herrup MIT Press, 2021. 272 pp.
    Science. 2021;374:267.
    PubMed     Abstract available
    
    
    August 2021
26. BLENNOW K
    Phenotyping Alzheimer's disease with blood tests.
    Science. 2021;373:626-628.
    PubMed    
    
    
    
27. SELKOE DJ
    Treatments for Alzheimer's disease emerge.
    Science. 2021;373:624-626.
    PubMed    
    
    
    July 2021
28. SERVICK K
    Alzheimer's drug approval spotlights blood tests.
    Science. 2021;373:373-374.
    PubMed    
    
    
    June 2021
29. SERVICK K
    Alzheimer's drug approved despite murky results.
    Science. 2021;372:1141.
    PubMed    
    
    
    December 2020
30. NAKAMURA T, Oh CK, Liao L, Zhang X, et al
    Noncanonical transnitrosylation network contributes to synapse loss in Alzheimer's disease.
    Science. 2020 Dec 3. pii: science.aaw0843. doi: 10.1126/science.aaw0843.
    PubMed     Abstract available
    
    
    November 2020
31. DARWICH NF, Phan JM, Kim B, Suh E, et al
    Autosomal dominant VCP hypomorph mutation impairs disaggregation of PHF-tau.
    Science. 2020;370.
    PubMed     Abstract available
    
    
    October 2020
32. BARTELS T, De Schepper S, Hong S
    Microglia modulate neurodegeneration in Alzheimer's and Parkinson's diseases.
    Science. 2020;370:66-69.
    PubMed     Abstract available
    
    
    
33. SIERKSMA A, Escott-Price V, De Strooper B
    Translating genetic risk of Alzheimer's disease into mechanistic insight and drug targets.
    Science. 2020;370:61-66.
    PubMed     Abstract available
    
    
    
34. NEDERGAARD M, Goldman SA
    Glymphatic failure as a final common pathway to dementia.
    Science. 2020;370:50-56.
    PubMed     Abstract available
    
    
    August 2020
35. SUZUKI K, Elegheert J, Song I, Sasakura H, et al
    A synthetic synaptic organizer protein restores glutamatergic neuronal circuits.
    Science. 2020;369.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: